By combining bioinformatic analysis and laboratory experiments, the characteristics of PD-L1 were presented in a systematic manner by the pan-cancer study in a number of areas, such as expression pattern, genetic mutation, survival prognosis, MSI, TMB, MMR, tumor immune micro milieu, medication sensitivity, and signaling pathway. This evidence concerns the gene CD274 and neoplasm.